NEUROLOGIX INC/DE (NRGX) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 129 transactions totaling $79.2M, demonstrating a bullish sentiment with $75.0M in net insider flow. The most recent transaction on Oct 26, 2023 involved a purchase of 4,300 shares valued at $81.1K.
No significant insider buying has been recorded for NRGX in the recent period.
No significant insider selling has been recorded for NRGX in the recent period.
Based on recent SEC filings, insider sentiment for NRGX is bullish with an Insider Alignment Score of 97/100 and a net flow of $75.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NEUROLOGIX INC/DE (NRGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading NRGX stock, having executed 129 transactions in the past 90 days. The most active insider is Daniel J. Ivascyn (Executive), who has made 12 transactions totaling $22.1M.
Get notified when executives and directors at NRGX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 26, 2023 | Weinstein Boaz | Executive | Purchase | 4,300 | $18.87 | $81.1K | |
| Oct 24, 2023 | Weinstein Boaz | Executive | Purchase | 511 | $19.00 | $9.7K | |
| Oct 17, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 79,249 | $19.32 | $1.5M | Large |
| Oct 16, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 40,681 | $19.24 | $782.7K | Large |
| Oct 5, 2023 | Weinstein Boaz | Executive | Purchase | 22,698 | $18.32 | $415.8K | |
| Sep 29, 2023 | Weinstein Boaz | Executive | Purchase | 130,725 | $19.79 | $2.6M | Large |
| Sep 27, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 154,516 | $18.70 | $2.9M | Large |
| Sep 25, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 16,657 | $17.50 | $291.5K | |
| Sep 22, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 32,061 | $17.25 | $553.1K | Large |
| Sep 21, 2023 | Weinstein Boaz | Executive | Purchase | 37,656 | $17.14 | $645.4K | Large |
| Sep 20, 2023 | Weinstein Boaz | Executive | Purchase | 51,659 | $17.23 | $890.1K | Large |
| Sep 13, 2023 | Weinstein Boaz | Executive | Purchase | 70,785 | $16.85 | $1.2M | Large |
| Sep 12, 2023 | Weinstein Boaz | Executive | Purchase | 82,006 | $16.92 | $1.4M | Large |
| Sep 7, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 44,016 | $17.18 | $756.2K | Large |
| Sep 6, 2023 | Management, L.p. Saba Capital | Executive | Purchase | 12,975 | $17.43 | $226.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 125 | $77.1M | 97.4% |
Sale(S) | 3 | $2.1M | 2.6% |
Other(J) | 1 | $0 | 0.0% |
Insiders at NEUROLOGIX INC/DE are accumulating shares at an accelerated pace. With 18 insiders making 129 transactions totaling $77.1M in purchases versus $2.1M in sales, the net buying activity of $75.0M signals strong executive confidence. Daniel J. Ivascyn (Executive) leads the buying activity with $22.1M in transactions across all time.